---
title: The Evolution of Oncology Clinical Pathways Utilization
description: With the rise of novel therapies, oncologists are looking to compare a set of therapies and predict outcomes, including survival rate, potential treatment delays due to unmanaged adverse events, and total cost of care.
---

# Newsroom

For Press Contact

[media@integraconnect.com](mailto:media@integraconnect.com)

Announcements

[In The News](https://insights.integraconnect.com/news?type=in-the-news) [Thought Leadership](https://insights.integraconnect.com/news?type=thought-leadership)

[

Back

](https://insights.integraconnect.com/news?type=in-the-news)

### The Evolution of Oncology Clinical Pathways Utilization

Sep 1, 2019

Specialty Practices

Click here to [read the original article at Journal of Clinical Pathways.](https://www.hmpgloballearningnetwork.com/site/jcp/article/evolution-oncology-clinical-pathways-utilization)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect",
    "url" : "https://insights.integraconnect.com/news/author/integra-connect"
  },
  "dateModified" : "2023-05-23T19:57:32.049Z",
  "datePublished" : "2019-09-01T12:00:00.000Z",
  "headline" : "The Evolution of Oncology Clinical Pathways Utilization",
  "mainEntityOfPage" : {
    "@id" : "https://insights.integraconnect.com/news/the-evolution-of-oncology-clinical-pathways-utilization",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://insights.integraconnect.com/hubfs/IntegraConnect%20/ic-logo-text-dark-gray.png"
    },
    "name" : "Integra Connect"
  }
}
```